Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel preparation of medicinal antiviral drug inhalant and preparation method thereof

A technology for antiviral drugs and inhalants, which is applied in the field of formulations to achieve the effects of reducing the degree of flocculation, promoting dissolution and improving surface properties

Active Publication Date: 2021-10-12
NANJING ZHIHE MEDICINE TECH CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] The diversity, variability, and high transmissibility of viruses are great challenges to public health security

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel preparation of medicinal antiviral drug inhalant and preparation method thereof
  • Novel preparation of medicinal antiviral drug inhalant and preparation method thereof
  • Novel preparation of medicinal antiviral drug inhalant and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-6

[0063] Embodiment 1-6: Ribavirin dry powder inhaler prescription:

[0064] Table 1-1 Components and dosages of Examples 1-6, specifications: 10-300mg (1 suction)

[0065]

[0066]

[0067] Table 1-2 Components and dosages of comparative examples 1 to 6, specifications: 20-100mg (1 suction)

[0068]

[0069]

[0070] Table 1-3 Performance tests of Examples 1 to 6

[0071]

[0072] Table 1-4 Performance tests of comparative examples 1 to 6

[0073]

[0074]

[0075] Table 1-5 Components and dosages thereof of Examples 7-9 and Comparative Examples 7-8, (1 suction)

[0076]

[0077] Table 1-6 Performance tests of Examples 7-9 and Comparative Examples 7-8

[0078]

Embodiment 10～18

[0080] Table 2-1 Components and dosages of Examples 10-15, specifications: 10-300mg (1 suction)

[0081]

[0082]

[0083] Table 2-2 Performance tests of Examples 10-15

[0084]

[0085] Table 2-3 Components and dosages of Examples 16-18, (1 suction)

[0086]

[0087]

[0088] Table 2-4 Performance tests of Examples 16-18

[0089]

Embodiment 19～21

[0091] Table 3-1 Components and dosages of Examples 19-21, (1 suction)

[0092]

[0093]

[0094] Table 3-2 Performance tests for implementing 19-21

[0095]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel preparation of a medicinal antiviral drug inhalant and a preparation method thereof. The novel preparation comprises a therapeutic agent, a coating agent, a suspending agent, a binding agent, a carrier and a cosolvent. The preparation disclosed by the invention not only has the effects of improving the surface performance of secondary particles and optimizing aerodynamics, but also can promote the dissolution and absorption of insoluble drugs and accelerate the effect after achieving the effect of improving the effective deposition rate in pulmonary alveoli.

Description

technical field [0001] The invention belongs to the field of pharmacy, and in particular relates to a novel preparation and preparation method of a pharmaceutical antiviral drug inhalation agent. Background technique [0002] The diversity, variability, and high transmissibility of viruses pose great challenges to public health security. After viral infection, high fever, general pain, and obvious fatigue often occur suddenly, and severe cases can even lead to pneumonia and respiratory failure. Influenza is a respiratory infectious disease caused by influenza virus, which is one of the major public health problems faced by human beings. The epidemiological characteristics of influenza are sudden outbreak, rapid spread, and widespread spread. Influenza has a high incidence rate and is generally susceptible. Influenza has severe clinical symptoms and a high incidence of complications, especially pneumonia, which can cause death. Anti-influenza virus treatment is one of the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/72A61K47/24A61K47/10A61K47/69A61K47/26A61K47/44A61K47/22A61K47/02A61K9/14A61K9/48A61K45/00A61K31/7056A61K31/404A61K31/4706A61K31/675A61K31/215A61K31/513A61K31/7105A61K38/21A61K31/427A61P31/12A61P31/14A61P11/00
CPCA61K9/0075A61K9/145A61K9/146A61K9/143A61K9/4858A61K9/4866A61K9/485A61K47/6951A61K45/00A61K31/7056A61K31/404A61K31/4706A61K31/675A61K31/215A61K31/513A61K31/7105A61K38/212A61K31/427A61P31/12A61P31/14A61P11/00
Inventor 张哲峰侯雯赵海峰
Owner NANJING ZHIHE MEDICINE TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com